| Direct Competitor Comparison | |
|---|
| PDLI | AMGN | SGEN | XOMA | Industry |
|---|
| Market Cap: | 1.15B | 79.22B | 4.42B | 349.78M | 71.76B |
|---|
| Employees: | 10 | 18,000 | 538 | 166 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.19 | 0.05 | 0.19 | -0.04 | 0.27 |
|---|
| Revenue (ttm):
| 389.03M | 17.46B | 219.90M | 33.37M | 13.93B |
|---|
| Gross Margin (ttm): | 1.00 | 0.84 | 0.12 | -0.14 | 0.72 |
|---|
| EBITDA (ttm): | 364.02M | 7.05B | -51.94M | -48.38M | 1.51B |
|---|
| Operating Margin (ttm):
| 0.93 | 0.34 | -0.26 | -1.57 | 0.13 |
|---|
| Net Income (ttm): | 224.96M | 4.60B | -57.75M | -65.53M | N/A |
|---|
| EPS (ttm): | 1.51 | 5.91 | -0.49 | -0.88 | 0.61 |
|---|
| P/E (ttm): | 5.43 | 17.88 | N/A | N/A | 18.43 |
|---|
| PEG (5 yr expected): | 0.36 | 1.54 | N/A | -0.26 | 1.51 |
|---|
| P/S (ttm): | 2.94 | 4.51 | 19.90 | 10.46 | 3.64 |
|---|
|
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.01 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | -0.01 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.02 | 85.82B | 31.52 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.01 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.02 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.02 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | -0.01 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.01 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.01 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | -0.01 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | -0.01 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | -0.01 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | -0.01 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.01 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
- SGEN
- A Portfolio Construction Strategy with an Emphasis on High-Innovation, Breakthrough Biotech and Pharmaceutical Companies Wall Street Transcript Thu, May 16
- SGEN
- SGEN's Adcetris under FDA Review Zacks Thu, May 16
- SGEN
- SEATTLE GENETICS INC /WA Financials EDGAR Online Financials Wed, May 15
- SGEN
- Seattle Genetics' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) at Seeking Alpha Wed, May 15
- XOMA
- XOMA CORP Financials EDGAR Online Financials Tue, May 14
- AMGN
- AFFY, AMGN, VRTX, and QCOR Early Briefing and Review Accesswire Wed, May 1
- SGEN
- StockCall Study on Gilead Sciences, NPS Pharma, InterMune, Seattle Genetics, and Halozyme Therapeutics Accesswire Wed, Apr 24
- AMGN
- Mid-day Buzzers: Goff Corp, Amgen, Sprint Nextel Corporation, Federal National Mortgage Association Accesswire Fri, Apr 12
- AMGN
- Arrayit's Potential as a Blockbuster Companion Diagnostic Accesswire Thu, Mar 7
- AMGN
- News Review: Microsoft Corporation, Pfizer Inc, Amgen Inc Accesswire Fri, Mar 1
- AMGN
- New Drug Could Enhance the Accuracy of Chemotherapy Accesswire Tue, Jan 29
- XOMA
- 10 Biotech Stocks Trading At The Deepest Discounts To Target Price at Seeking Alpha Wed, Nov 30
- XOMA
- 20 Healthcare Stocks Deeply Undervalued By Target Price at Seeking Alpha Wed, Nov 23
- XOMA
- 20 Healthcare Stocks With Positive Receivables Trends at Seeking Alpha Wed, Nov 16
- XOMA
- XOMA's CEO Presents at the Eighth Annual Lazard Capital Markets Healthcare Conference - Conference Call Transcript at Seeking Alpha Wed, Nov 16
All headlines for these symbols... Currency in USD. | |
|
0.04(0.49%) May 17, 4:00PM EDT|After Hours
:
8.20